CORDIS call2021

HORIZON-HLTH-2021-IND-07

HORIZON-HLTH-2021-IND-07

Programme
HORIZON
Funded projects (dataset)
6
EU contribution (sum)
€37,124,155
Portal deadline

Leading topic in historical projects: HORIZON-HLTH-2021-IND-07-01

Start here

Suggested partners for this call

Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.

Top coordinators

Organisations that coordinated the most funded projects under this call.

Organisations strong on this topic

Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).

Proposal partner finder

One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.

Typical consortium pattern

Derived from historical funded projects linked to this CORDIS call in Grantibase.

Avg. orgs / project
15.33
Median orgs / project
15.5
Min / max orgs
1020

Country presence

Participant rows (an org can appear in multiple countries if data varies).

  • Germany13
  • Netherlands10
  • United Kingdom9
  • Belgium8
  • Spain8
  • Italy8
  • Ireland5
  • Greece5
  • France4
  • Switzerland4
  • Portugal4
  • Austria3
  • Lithuania2
  • Finland2
  • Cyprus1
  • Estonia1
  • Latvia1
  • Denmark1

Organization types

  • university27 orgs · 30 rows
  • sme21 orgs · 21 rows
  • research_institute18 orgs · 18 rows
  • company17 orgs · 17 rows
  • other6 orgs · 6 rows

Topics in funded projects

Related funded projects

Largest EU contributions in this call — useful to see who already won funding on similar lines.

Open full project list in advanced search

ProjectEU contribution
TransPharm

Transforming into a sustainable European pharmaceutical sector

€8,039,600
ENVIROMED

Next generation toolbox for greener pharmaceuticals design & manufacturing towards reduced environmental impact

€7,518,062
IMPACTIVE

Innovative Mechanochemical Processes to synthesize green ACTIVE pharmaceutical ingredients.

€7,438,705
SusPharma

MERGING SUSTAINABLE AND DIGITAL CHEMICAL TECHNOLOGIES FOR THE DEVELOPMENT OF GREENER-BY-DESIGN PHARMACEUTICALS

€6,205,435
ETERNAL

Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.

€5,922,396
Label2Enable

Adopting ISO 82304-2 and a trusted EU mHealth label for a single market that enables patients, citizens, health professionals, systems and authorities to benefit from a healthy supply of useful apps.

€1,999,957